Bentyl: profile and news

/FIRST AND FINAL ADD - MO237 - Axcan reports fourth quarter and ... Nov 10, 2005
The acquired products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market. ... - PR Newswire (press release),

Axcan reports fourth quarter and year-end 2005 financial results ... Nov 10, 2005
These products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market (collectively, "AVAX" product line). ... - Yahoo! News (press release)

ADD: /FIRST AND FINAL ADD - MO056 - Axcan announces third quarter ... Sep 28, 2005
The acquired products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market. ... - Investor's Business Daily (subscription)

Acmemeds.com Improves Itself With 101 New Added Medications Aug 20, 2005
...mg, Amoxicillin 500 mg, Antivert (generic) 12.5 mg, Antivert 12.5 mg, Antivert 50 mg, Aphthasol 5% 5 gm Ointment, Atarax (generic) 50 mg, Bentyl (generic) 10 mg ... - PR Web (press release),

/FIRST AND FINAL ADD - MO056 - Axcan announces third quarter 2005 ... Aug 11, 2005
The acquired products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market. ... - PR Newswire (press release),

Axcan announces third quarter 2005 results Aug 11, 2005
These products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market (collectively, "AVAX" product line). ... - CNW Telbec (Communiqués de presse),

Luck runs out on trip back from Atlantic CityLuck runs out on trip ... Jul 15, 2005
The hospital gave Jean augmentin for the infection, bentyl for abdominal relief, and percocet for pain relief, but percocet is something that Jean cannot take. ... - Ocean City

/FIRST AND FINAL ADD - MO211 - AXCAN PHARMA INC. EARNINGS/ May 4, 2005
The acquired products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market. ... - PR Newswire

Axcan reports second quarter 2005 results May 4, 2005
These products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market (collectively, "AVAX" product line). ... - CNW Telbec (Communiqués de presse),

Axcan Reports First Quarter 2005 Results Feb 14, 2005
The acquired products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market. ... - PR Newswire (press release)

Axcan Reports First Quarter 2005 Results Feb 14, 2005
These products are CARAFATE and BENTYL for the US market and SULCRATE, BENTYLOL and PROCTOSEDYL for the Canadian market (collectively, "AVAX" product line). ... - Canada NewsWire (press release),

Other information

Indication
For the treatment of functional bowel/irritable bowel syndrome including Colicky abdominal pain;Diverticulitis

Pharmacology
Dicyclomine is an anticholinergic drug, a medication that reduces the effect of acetylcholine, a chemical released from nerves that stimulates muscles, by blocking the receptors for acetylcholine on smooth muscle (a type of muscle). It also has a direct relaxing effect on smooth muscle. Dicyclomine is used to treat or prevent spasm in the muscles of the gastrointestinal tract in the irritable bowel syndrome. In addition, Dicyclomine inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions.

Mechanism Of Action
Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic).

Drug Category
Anticholinergic Agents; Antispasmodics; Antimuscarinics; Antispasmodics; ATC:A03BA

Brand Names/Synonyms
Atumin; Bentomine; Bentyl; Bentyl Hydrochloride; Bentylol; Bentylol Hydrochloride; CHEMBANK819; Di-Syntramine; Dicicloverina [Inn-Spanish]; Dicyclomine; Dicyclomine Hcl; Dicyclomine Hydrochloride; Dicycloverin; Dicycloverin Hydrochloride; Dicycloverine; Dicycloverine Hydrochloride; Dicycloverinum [Inn-Latin]; Diethylaminocarbethoxybicyclohexyl Hydrochloride; Diocyl; Diocyl Hydrochloride; Dyspas; Formulex; HSDB 3058; Kolantyl Hydrochloride; Mamiesan; Merbentyl; Oxityl-P; Procyclomin; Sawamin; Spasmoban; Wyovin; Wyovin Hydrochloride

Dosage Forms
CAPSULE

Absorption
Not Available

Interactions
Interactions for Dicyclomine:

The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines. MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.

Anticholinergics antagonize the effects of antiglaucoma agents. Anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corti costeroids..

Anticholinergic agents may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of digoxin; increased serum digoxin concentrations may result.

Anticholinergic drugs may antagonize the effects of the drugs that alter gastrointestinal motility, such as metoclopramide. Because antacids may interfere with the absorption of anticholinergic agents, simultaneous use of these drugs should be avoided.

The inhibiting effects of anticholinergic drugs on gastric hydrochloric acid secretion are antagonized by agents used to treat achlorhydria and those used to test gastric secretion.

Chemical IUPAC Name
2-diethylaminoethyl1-cyclohexylcyclohexane-1-carboxylate

Chemical Formula
C19H35NO2

Half Life
Not Available

Drug Type
Approved Drug

# Accession No
APRD00113

CAS Registry Number
77-19-0